NEUBERG DIAGNOSTICS LAUNCHES NEUBERG CENTER FOR GENOMIC MEDICINE
- NCGM inaugurates NOVASEQ 6000
- Neuberg inks its intention to collaborate with CSIR Institute of Genomics and Integrative Biology (CSIR-IGIB) for licensing of technologies / know-how for various genomics-scale biomedical applications.
Ahmedabad, November 27, 2019: Neuberg Diagnostics Private Limited (NDPL), ranking among the top 4 diagnostic service providers in the country, today launched Neuberg Center for Genomic Medicine (NCGM). Dr.Anurag Agrawal, Director, CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB) and Head of Translational Research in Lung Diseases, inaugurated the Center and informed about CSIR-IGIB’s in principal agreement to partner with NDPL forlicensing of technologies for various genomics-scale healthcare applications including population-scale whole genome sequencing, knowledgebase for which has been developed at CSIR-IGIB.
The Neuberg Center for Genomic Medicines strengths encompass comprehensive Genomics Core facility allowing for large-scale clinical and research projects including whole exome sequencing, whole genome sequencing, proteomics, high content screening and cytogenetics. Moreover, NCGM is extremely unique in its organizational structure consisting of a dedicated team of translational scientists trained with both Medical (MD) and/or research (PhD) training, heading each unit such as Immunogenetics, Solid Oncology, Hemato-oncology, Reproductive Medicine, Infectious Diseases, Inherited Genomics as well as Bioinformatics.
NCGM today also inaugurated the NOVASEQ 6000, the highest throughput DNA sequencer currently available in the world. With its acquisition, NCGM is the only private lab in country to house themost powerful sequencer which offers high-throughput sequencing across a broad range of applications.Itsupports the study of genetic links between health and disease at an unprecedented scale by making it possible to sequence more samples at greater depth, in order to discover rare and novel genetic variants. This advanced sequencing system will make it possible to envision a future in which all people can benefit from Precision Medicine.
Dr. Sandip Shah, Executive Director, Neuberg Diagnostics Private Limited, commented at the launch, “NovaSeq 6000 will help researchers access next-generation sequencing technology and more easily conduct large-scale genomics projects with greater sample volumes at an unprecedented depth and coverage of the genome.”
Commenting during the launch, Dr. G. S. K. Velu, Chairman & Managing Director, Neuberg Diagnostics Private Limitedsaid “Neuberg’s focus and aim have always been technological advancement in medicine. The launch of NovaSeq is a proud moment for us as not only are we bringing the best technology to India but we are also the only private company to bring this technology. Being the most advanced and powerful sequencer, NovaSeq will enable us to attain a deeper understanding of the human genome as we strive to uncover causes and treatments for various complex disorders”
Neubergintentsto collaborate with CSIR-IGIB, the premier laboratory of CSIR, having demonstrated expertise in Genomics with aim to utilize India’s intrinsic sequencing capacity and showcase the tremendous advantage of employing local technical resources and manpower across India’s public and private sector as we work to fulfil the mission of ‘Make in India’.
Dr. Anurag Agrawal, Director, CSIR Institute of Genomics and Integrative Biology (CSIR-IGIB) said, “Health ecosystems of future will be based on the idea of digital twins, our digital health equivalents, monitored and evaluated by wellness algorithms. Genomics is at the core of these concepts and I am delighted to see that the Indian private sector is now working in concert with academic organizations for creating next-generation services of social and economic importance to India.”
About CSIR-Institute of Genomics and Integrative Biology
CSIR-IGIB is a premier laboratory of Council for Scientific and Industrial Research (CSIR), India and is engaged in research of national importance in the areas of Genomics, Molecular Medicine, Bioinformatics and Proteomics. CSIR-IGIB has expertise in genomics, demonstrated through the Indian Genome Variation project, the sequencing of first Indian personal genome followed by genome sequencing of over 1000 individuals from India and ongoing clinical genomics efforts in rare and common diseases with a large number of public and private healthcare institutions in the country.
About Neuberg Diagnostics
The best-in-class laboratories from across India, UAE & South Africa have united under the banner ofNeuberg Diagnostics to bring the latest technology and techniques within the reach of developing countries.Utilizing their combined strengths, the Neuberg alliance brings capabilities to perform over 6000 varieties ofPathological investigations and will promote Prevention & Early Diagnosis, Focused Wellness Programsand Structured Disease Management programs for rare diseases using the most advanced technologiesassisted by Data science and AI tools. Today, Neuberg Diagnostics is among the top diagnostics companies ofIndian origin and the fastest growing healthcare start-up in India. The founding members of the Neubergconsortium – Anand Diagnostic Laboratory (Bangalore), Supratech Micropath (Ahmedabad), Ehrlich Laboratory(Chennai), Global Labs (South Africa), and Minerva Diagnostics (Dubai) bring their combined heritage of over200 years and process over 20 million samples annually. Some of the best Pathologists, Biochemists,Geneticists, Microbiologists, and several other Clinical Lab Professionals from around the world are working closely, sharing knowledge and using the latest generation of diagnostics techniques to takeaccurate and timely diagnosis to the next level.
